Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RNA
Biotech
AIRNA preps for clinical test with $155M series B
AIRNA's tech makes targeted adenosine-to-inosine edits in RNA, which the firm hopes can provide a functional cure for alpha-1 antitrypsin deficiency.
Darren Incorvaia
Apr 1, 2025 7:00am
Eli Lilly jumps deeper into AI with $409M Genetic Leap deal
Sep 5, 2024 9:16am
Pfizer signs $331M deal with Ginkgo for unspecified targets
Sep 27, 2023 9:50am
New RNA biotech raises $300M in largest private round of 2023
May 23, 2023 6:30am
Oncorus lays off 15% of workforce, drops solid tumor prospect
Nov 30, 2022 10:55am
Merck bets big on circular RNA, paying $150M to work with Orna
Aug 16, 2022 9:00am
